Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Hikma Pharmaceuticals Plc    HIK   GB00B0LCW083

Delayed Quote. Delayed  - 03/27 05:35:12 pm
2000 GBp   -0.05%
03/24 British stocks close flat Monday
03/23 DIRECTOR DEALIN : Hikma Executive Sells 43,000 Shares
03/20 British shares edge up slightly
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

British stocks close flat Monday

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/24/2017 | 11:55pm CEST

British shares closed flat on Monday, with the benchmark FTSE 100 Index up 0.07 percent, or 4.85 points, to finish at 7,429.81 points.

Multinational private equity and venture capital company 3i Group advanced 1.8 percent, the top gainer of the blue chips.

British major chain of supermarkets gained 1.71 percent. Direct Line Insurance Group went up 1.7 percent.

Royal Bank of Scotland shedded 1.64 percent and became the top loser of the blue chips. Hikma Pharmaceuticals lost 1.57 percent. Packaging firm Smurfit Kappa went down 1.25 percent.

(c) 2017 Philippines News Agency Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HIKMA PHARMACEUTICALS PLC
03/24 British stocks close flat Monday
03/23 DIRECTOR DEALINGS : Hikma Executive Sells 43,000 Shares
03/20 British shares edge up slightly
03/17 HIKMA PHARMACEUTICALS : 14.7% Potential Upside Indicated by Cantor Fitzgerald
03/17 HIKMA PHARMACEUTICALS : *hsbc cuts hikma pharmaceutical to 'reduce' ('hold') - t..
03/17 *TRADERS : Hsbc cuts hikma pharmaceutical to 'reduce' ('hold')
03/16 HIKMA PHARMACEUTICALS : - Notice of results
03/16 HIKMA PHARMACEUTICALS : delivers a solid financial performance in 2016 and makes..
03/16 HIKMA PHARMACEUTICALS : *jpmorgan cuts hikma pharma to 'neutral' (overw.) - targ..
03/16 *TRADERS : Jpmorgan cuts hikma pharma to 'neutral' ('overweight') - target 2400 ..
More news
Sector news : Pharmaceuticals - NEC
03/27DJALEXION PHARMACEUTICALS : Names New CEO Following Internal Sales-Practice Probe
03/27DJEU Clears Dow-DuPont Deal With Conditions -- 2nd Update
03/27DJEU Clears Dow-DuPont Deal With Conditions -- Update
03/27 Chinese drug approval boosts AstraZeneca's lung cancer hopes
03/24 NOVO NORDISK A/S : EMA panel backs Novo Nordisk's haemophilia B drug
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
03/15 Hikma Pharmaceuticals' (HKMPF) CEO Said Darwazah on Full Year 2016 Results - ..
03/15 Hikma Pharmaceuticals reports FY results
03/15 Hikma Pharmaceuticals plc. 2016 Q4 - Results - Earnings Call Slides
03/08 Glaxo Mounts Final Push As U.S. Advair Generics Loom
02/01 Teva's $1bn Copaxone Blow
Advertisement
Financials ($)
Sales 2017 2 191 M
EBIT 2017 478 M
Net income 2017 269 M
Debt 2017 409 M
Yield 2017 1,29%
P/E ratio 2017 21,49
P/E ratio 2018 16,37
EV / Sales 2017 2,92x
EV / Sales 2018 2,58x
Capitalization 5 987 M
More Financials
Chart HIKMA PHARMACEUTICALS PLC
Duration : Period :
Hikma Pharmaceuticals Plc Technical Analysis Chart | HIK | GB00B0LCW083 | 4-Traders
Full-screen chart
Technical analysis trends HIKMA PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 29,1 $
Spread / Average Target 17%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Samih Said Samih Darwazah Chairman & Chief Executive Officer
Khalid Nabilsi Chief Financial Officer
Ibrahim Jalal Senior Vice President-Technical Affairs
Ragheb Al-Shakhshir Vice President-Research & Development
Michael Richard Dwyer Ashton Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
HIKMA PHARMACEUTICALS ..5.71%6 011
JOHNSON & JOHNSON8.91%340 163
ROCHE HOLDING LTD.8.73%219 545
PFIZER INC.4.68%202 474
NOVARTIS AG-0.94%195 096
MERCK & CO., INC.7.32%173 465
More Results